May 16, 2017
Correction: The original version of this story misstated the study population.
Improving medication adherence is on the wish list of many healthcare stakeholders. Given the multitude of reasons why people don’t stick with their prescriptions, there isn’t just one successful modality to improve their adherence.
But a small study suggests using text messages to engage in two-way communication with...
May 5, 2017
Crystal Lake, Illinois-based Aptar Pharma is teaming up with digital health startup Kali Care to develop a new way of measuring adherence to eye drops in clinical trials.
Because they are somewhat onerous to use, eye drops have even lower rates of adherence than other medications. Kali Care, based in Silicon Valley, makes a small sensor that can be installed in a container for eye drop...
May 2, 2017
Seattle, Washington-based Pillsy has officially launched its digital medication adherence and tracking tool, which consists of a smart pill bottle and companion app.
PillsyCap, as the product is known, uses Bluetooth to sense when the bottle is opened and closed, and syncs with the app to automatically tracks when a user takes their pills, reminds them when they forget a dose or warns if multiple...
May 1, 2017
Catalia Health, which makes an AI-powered patient engagement robot called Mabu, has raised $2.5 million in a new round led by Khosla Ventures. Additional investments came from new investors NewGen Capital and Macnica Ventures and existing investors Q Venture Partners Limited, InnoLinks Ventures, Abstract by Flight.VC, DeNA and Lucky Capital. This brings the company's total funding to $3.75...
April 7, 2017
A forthcoming 28-patient study in the American Heart Association's journal Stroke shows that AiCure's artificial intelligence platform led to a 50 percent improvement in adherence to oral anticoagulants.
In the study, a cohort of 28 ischemic stroke survivors was followed for 12 weeks. Fifteen were assigned to the intervention group that used AiCure's software to monitor their adherence daily, and...
March 14, 2017
Digital health company Mango Health, which makes a gamified app for patient engagement and medication adherence, has announced a strategic investment from — and longterm partnership with — Express Scripts, the largest pharmacy benefit management organization in the United States. The amount of the investment was undisclosed.
Through the deal, Express Scripts’ 85 million clients will have access...
March 1, 2017
Medication adherence startup MediSafe has raised $14.5 million in a round led by Octopus Ventures and M Ventures (the venture arm of Merck Pharmaceuticals), with participation from existing investors Pitango Venture Capital, 7wire ventures, lool Ventures, TriVentures and Qualcomm Ventures. The company also announced that it will begin expanding into Europe using some of the funds.
November 17, 2016
Correction: A previous version of this article misstated the adherence figure.
Adherium’s Smartinhaler has been shown to increase medication adherence by 43 percent and reduce hospitalization by a factor of five, according to a new study conducted at Sheffield Children’s Hospital in the UK and published in the journal Thorax. The randomized control trial included 77 children with asthma.
November 16, 2016
Around the world, pharmaceutical companies are losing $637 billion in revenue per year from a multifaceted, but common problem: people with chronic conditions are not adhering to their medication.
In a research paper by medication adherence company HealthPrize Technologies and consulting company Capgemini, the issue was described as “one of the most serious problems in healthcare,” affecting all...
November 14, 2016
Intent Solutions, an Atlanta-based company working on a connected medication dispenser called TAD, has raised $1.5 million in seed funding. The company did not disclose the investors.
"We have been quietly raising capital for several months while refining our technology and service offerings," Sam Zamarripa, president of Intent Solutions, said in a statement. "In that time, we've developed...